-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Achilles Therapeutics plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q2 2024.
- Achilles Therapeutics plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$16.4M, a 2.77% increase year-over-year.
- Achilles Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2023 was -$69.7M, a 2.12% increase from 2022.
- Achilles Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2022 was -$71.2M, a 16.5% decline from 2021.
- Achilles Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2021 was -$61.1M, a 84% decline from 2020.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)